Construction of an Ultrasound Profile and a Mammographic Profile Corresponding to the Different Molecular Subtypes of Brest Cancer. A Retrospective Study
Launched by ELSAN · Feb 24, 2023
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women diagnosed with a breast cancer
- • Detection of a breast cancer during the screening campaign organized between june 2015 and july 2018 in the following geographic zones : Cantal, Haute Loire and Puys de Dôme
- Exclusion Criteria:
- • Patients who expressed their opposition to the use of their personal data
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials